Armed with the power of epigenomics, we’re shattering the norms of skin health by unlocking precious biological insights non-invasively.
Picture this: a world where skin data isn’t a secret locked behind invasive biopsies. Our mission? To disrupt the status quo and liberate skin data from its biopsy chains. Diagnostics and groundbreaking treatments demand skin’s innermost truths, and we’re delivering – no scalpel required.
We extract biological data from the skin using non-invasive sampling, next-generation sequencing and data science. The resulting platform is being used by some of the world’s leading skincare and pharmaceuticals to inform product efficacy and discovery of novel longevity molecules.
12-month fixed-term contract | London preferred Company description Mitra Bio has developed a non-invasive skin sampling that can detect molecular changes in the skin non-invasively. The Company has been awarded the prestigious European Innovation Council grant to develop a non-invasive molecular test for screening moles...
About Mitra Bio Mitra Bio is building the future of skincare through epigenetics, longevity science and AI. We use non-invasive skin sampling and advanced data science to understand how skin changes over time, identify biomarkers of skin health and ageing, and translate complex biological data...
We are launching the world’s first skin epigenetic test. A non-invasive patch that reads your skin biology so you can shape how it’s aging. Join the waitlist to be first to try it when we launch
